Results 1 to 10 of about 258,627 (303)

Glycine and glycine receptor signalling in non-neuronal cells [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2009
Glycine is an inhibitory neurotransmitter acting mainly in the caudal part of the central nervous system. Besides this neurotransmitter function, glycine has cytoprotective and modulatory effects in different non-neuronal cell types.
Jimmy Van Den Eynden   +8 more
doaj   +6 more sources

Impaired Verbal Memory Recall in Patients With Axonal Degeneration and Serum Glycine-Receptor Autoantibodies—Case Series [PDF]

open access: yesFrontiers in Psychiatry, 2022
BackgroundGlycine receptor antibody-associated neuropsychiatric disease is currently known to be dominated by the phenotypes stiff-person syndrome and progressive encephalomyelitis entailing rigidity and myoclonus. In our case series we aim to depict the
Niels Hansen   +6 more
doaj   +2 more sources

Molecular determinants of cesium- and glycine-dependent glycine receptor activation [PDF]

open access: yesScientific Reports
The neurotransmitter receptor for glycine (GlyR) is a ligand-gated chloride-permeable ion channel in the central nervous system, and dysregulation of this channel is associated with diverse neurological disorders. Cesium (Cs+) is an agonist of GlyRs, and
Magnus Harnau   +3 more
doaj   +2 more sources

Glycine receptor autoantibody binding to the extracellular domain is independent from receptor glycosylation [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2023
Glycine receptor (GlyR) autoantibodies are associated with stiff-person syndrome and the life-threatening progressive encephalomyelitis with rigidity and myoclonus in children and adults.
Vera Rauschenberger   +13 more
doaj   +2 more sources

The emerging role of glycine receptor α2 subunit defects in neurodevelopmental disorders [PDF]

open access: yesFrontiers in Molecular Neuroscience
Rare neurodevelopmental disorders (NDDs) are one of the most significant unmet challenges in healthcare due to their lifelong nature, high management costs, and recurrence within families.
Sean D. Fraser   +3 more
doaj   +2 more sources

Differentiated human midbrain-derived neural progenitor cells express excitatory strychnine-sensitive glycine receptors containing α2β subunits. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: Human fetal midbrain-derived neural progenitor cells (NPCs) may deliver a tissue source for drug screening and regenerative cell therapy to treat Parkinson's disease.
Florian Wegner   +7 more
doaj   +1 more source

Positive Modulation of the Glycine Receptor by Means of Glycine Receptor–Binding Aptamers [PDF]

open access: yesSLAS Discovery, 2015
According to the gate control theory of pain, the glycine receptors (GlyRs) are putative targets for development of therapeutic analgesics. A possible approach for novel analgesics is to develop a positive modulator of the glycine-activated Cl(-) channels.
Shalaly ND   +8 more
openaire   +5 more sources

Inhibitory Glycine Receptors: An Update [PDF]

open access: yesJournal of Biological Chemistry, 2012
Strychnine-sensitive glycine receptors (GlyRs) mediate synaptic inhibition in the spinal cord, brainstem, and other regions of the mammalian central nervous system. In this minireview, we summarize our current view of the structure, ligand-binding sites, and chloride channel of these receptors and discuss recently emerging functions of distinct GlyR ...
Dutertre, Sebastien   +2 more
openaire   +6 more sources

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia

open access: yesFrontiers in Psychiatry, 2020
Treatment-resistant schizophrenia (TRS) or suboptimal response to antipsychotics affects almost 30% of schizophrenia (SCZ) patients, and it is a relevant clinical issue with significant impact on the functional outcome and on the global burden of disease.
Andrea de Bartolomeis   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy